UK-based Avacta Group, a life sciences company developing targeted oncology drugs and powerful diagnostics, has announced that a second milestone equity payment has been triggered resulting in an increase in Avacta’s…
UK-based Avacta Group, a life sciences company developing targeted oncology drugs and powerful diagnostics, has announced that a second milestone equity payment has been triggered resulting in an increase in Avacta’s…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


